Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Am J Obstet Gynecol MFM. 2023 Jan 17;5(6):100861. doi: 10.1016/j.ajogmf.2023.100861

Table 1.

Outcomes of IRB models used in CHAP trial.

Shared IRB
(N=7)
Individual IRB
(N=38)
p-value
Time from initial submission to final approval, days 41 (7–165) 56 (0–183) 0.424
Time from initial submission to final approval greater than 60 days: N (%) 2 (29%) 16 (42%) 0.684
Number of IRB submission rounds 1 (1–2) 2 (0–6) 0.087
Number of stipulations from IRB prior to approval 1 (0–6) 4 (0–70) 0.122
Total number of full IRB meetings prior to approval; N (%)
 None
 One
 Two
 Three

6 (86%)
1 (14%)
0 (0%)
0 (0%)

1 (3%)
25 (63%)
11 (29%)
1 (3%)
<0.001



Kruskal-Wallis Test

Fisher’s Exact Test

All data are median (range) unless otherwise specified (Hub site=Individual IRB).